Search research articles
Contact Us
Filters
Showing results (41-50 of 119) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2008
A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas
Lia Gore, Mace L Rothenberg, Cindy L O'Bryant, et al.
British Journal of Clinical Pharmacology
|
November 15, 2018
Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies
Ying Ou, Yang Xu, Lia Gore, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
Elaine T Lam, Cindy L O'Bryant, Michele Basche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group
Lia Gore, S Percy Ivy, Frank M Balis, et al.
Pediatric Blood & Cancer
|
November 6, 2008
Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability
Lia Gore, Sant Chawla, Antonio Petrilli, et al.
Journal of the National Cancer Institute
|
March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials data
Margaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
American Journal of Hematology
|
June 4, 2014
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia
Lori A Gardner, Jelena Klawitter, Mark A Gregory, et al.
Investigational New Drugs
|
September 21, 2011
Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
Lia Gore, E Rivera, M Basche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors
Razelle Kurzrock, Amita Patnaik, Joseph Aisner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2017
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
Birgit Geoerger, Christophe Bergeron, Lia Gore, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 119) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2008
A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas
Lia Gore, Mace L Rothenberg, Cindy L O'Bryant, et al.
British Journal of Clinical Pharmacology
|
November 15, 2018
Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies
Ying Ou, Yang Xu, Lia Gore, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
Elaine T Lam, Cindy L O'Bryant, Michele Basche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group
Lia Gore, S Percy Ivy, Frank M Balis, et al.
Pediatric Blood & Cancer
|
November 6, 2008
Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability
Lia Gore, Sant Chawla, Antonio Petrilli, et al.
Journal of the National Cancer Institute
|
March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials data
Margaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
American Journal of Hematology
|
June 4, 2014
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia
Lori A Gardner, Jelena Klawitter, Mark A Gregory, et al.
Investigational New Drugs
|
September 21, 2011
Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
Lia Gore, E Rivera, M Basche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors
Razelle Kurzrock, Amita Patnaik, Joseph Aisner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2017
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
Birgit Geoerger, Christophe Bergeron, Lia Gore, et al.
Page
of 12